Therefore, we performed the present study to explore the association of lncRNA NEAT1 with MM risk and further investigate its correlation with clinical features, treatment response, survival profiles, and its interaction with miR‐125a in MM patients. The gene discussed is NEAT1; the disease is Miyoshi myopathy.